HEART PROCEDURE SUPERIOR TO DRUGS FOR COMMON ARRHYTHMIA A minimally invasive procedure that “rewires” ‌the heart may be a ...

AVANT GUARD trial meets expectations despite pause for safety modifications ...

In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...

A major international trial has found that pulsed-field catheter ablation offers superior outcomes to antiarrhythmic drugs ...

There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.

For ventricular tachycardia (VT), catheter ablation is often seen as an option of last resort, however, some are questioning whether there has been too much emphasis on antiarrhythmic medication. In ...

The authors' work is supported by the European Network for Translational Research in Atrial Fibrillation (EUTRAF, No. 261057), the German Federal Ministry of Education and Research (AF Competence ...

Tasigna (nilotinib) is a brand-name oral capsule prescribed for a certain type of chronic myeloid leukemia (CML). Tasigna can interact with some other drugs, such as certain antiarrhythmic medications ...

A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation nearly doubles the success rate of treating persistent atrial fibrillation compared with medication. One year after ...